about
Modulation of tumor necrosis factor by microbial pathogens.Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathwayThrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1Targeting microRNAs as key modulators of tumor immune responseInsight to drug delivery aspects for colorectal cancerThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentRegulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinologyGenetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.Non-linear dimensionality reduction of signaling networks.Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysisTumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancerThe immunobiology of mushrooms.Relationship of inflammatory markers and pain in patients with head and neck cancer prior to anticancer therapy.Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis.A cytokine-mediated link between innate immunity, inflammation, and cancer.Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivoAffinity Purification of Tumor Necrosis Factor-α Expressed in Raji Cells by Produced scFv Antibody Coupled CNBr-Activated Sepharose.Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumorsEffective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubesMUC1 alters oncogenic events and transcription in human breast cancer cells.Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.Chronic inflammation in cancer development.Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.Expression of Inflammatory and Cell Death Program Genes and Comet DNA Damage Assay Induced by Escherichia coli in Layer Hens.Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.The efficacy of betulinic acid in triple-negative breast cancer.Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancerDeficiency of iPLA₂β Primes Immune Cells for Proinflammation: Potential Involvement in Age-Related Mesenteric Lymph Node LymphomaTumour necrosis factor: implications for surgical patients.Development and dynamics of robust T-cell responses to CML under imatinib treatmentRandomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsTumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cellsA New Herbal Formula, KSG-002, Suppresses Breast Cancer Growth and Metastasis by Targeting NF- κ B-Dependent TNF α Production in MacrophagesTNF-α, a good or bad factor in hematological diseases?Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer.
P2860
Q21089629-D31A2C07-A7E8-471A-B3CF-023CCF65C8D8Q21245702-B0783513-40B8-4C9E-9671-0E11AFF708FCQ24336644-0AE6DF5E-02DE-4D05-B1EE-101112496E0CQ26746972-31E4E3D0-D505-440B-91AE-FE6F07E1F505Q26774682-8EE77D33-B923-45A0-9D52-05E265D50B62Q28241308-EB9168DF-C7C9-4535-9BB7-10859EBB8A43Q28386983-16BDF515-C947-411E-A703-7C44A6158701Q30855755-A17D34AC-CF17-456F-84DE-F21F1EA43A03Q31022986-FA903673-CB18-428B-AC3C-91F7B7EC4C7FQ33287221-58328D6D-1838-4339-B465-097E045F885AQ33318715-62A80A3A-B3BE-4D51-8030-3F93FA8BEE9FQ33614221-FA72C9E5-0ED5-406D-8268-D081C7D0F034Q34010091-844DF025-9159-4F56-B8B5-EEF678F81589Q34010686-F96CD194-AA1E-4A73-A934-638A54B5C34EQ34275796-7303876E-4058-4818-A79E-B4C0C6974CE5Q34515863-BC08DD90-DEE6-49D1-A165-F79003AFD49CQ34625152-F59D3EFA-F77E-42C8-9E1F-3502FB658CD1Q35024044-AE62EC30-7DC8-41EB-B671-4D868C878A2CQ35061620-25282502-5528-42CA-88AB-8FDE9E8F789CQ35221363-02949F3F-8D1F-4E46-94F9-5EEE4CE042DAQ35234708-CC5F0D40-791C-4A52-A1AB-3A841D7B7009Q35605728-F5380725-E25F-4CFE-9C78-263AA1C1A44DQ35751039-ED75A730-F11A-47E4-A847-21EB3001780AQ35871833-967236F3-91D5-43D3-9214-2D84015F0B47Q35928265-682F58EF-47F9-4077-B2F0-2C2E184CA2AEQ35953268-61078D9A-FAB8-4B6A-8AC4-B3D50C18ABC5Q36062201-11EBE7D9-A362-47E1-8F7A-532CE35CF1ABQ36143638-E6B01AFD-50A0-4BD5-932D-53EB8E07FA1FQ36165932-E788A20C-EE3F-4F66-AC85-AE6069BC9EE1Q36250668-7C13A376-9FB0-413A-8E45-FE6065ED43C5Q36416156-4D59B5D6-425B-4DB8-AA3B-C8492FFB4B5FQ36630054-3086A5B9-4843-45C5-AC98-855A3172E593Q36677315-6F3B8378-21A5-4298-8BC8-432D6BC4DD14Q36764997-73223956-9076-4E26-B413-FEA2FAE4BE93Q36796779-F8F29CF6-0665-4BD8-A1F3-0F52764483E4Q36931363-916006E6-B191-405F-889B-02FBC52427BBQ37043776-E4C72334-A619-475E-96F2-3DCF11ED88AAQ37220415-F06B7C86-E99A-4499-AC6C-F872DB731363Q37287166-D6C88F1B-F8FF-4F30-9EAC-BE1751A96806Q37294534-0BE3BD20-A807-4FC6-8E7F-5F34B29C71F2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tumor necrosis factor, cancer and anticancer therapy.
@ast
Tumor necrosis factor, cancer and anticancer therapy.
@en
type
label
Tumor necrosis factor, cancer and anticancer therapy.
@ast
Tumor necrosis factor, cancer and anticancer therapy.
@en
prefLabel
Tumor necrosis factor, cancer and anticancer therapy.
@ast
Tumor necrosis factor, cancer and anticancer therapy.
@en
P1476
Tumor necrosis factor, cancer and anticancer therapy
@en
P2093
Donato Nitti
Simone Mocellin
P356
10.1016/J.CYTOGFR.2004.11.001
P577
2004-12-19T00:00:00Z